Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.3B | 3.8B | 3.6B | 3.1B |
Cost of revenue | 1.9B | 2.3B | 2.1B | 1.7B |
Gross profit | 1.4B | 1.5B | 1.5B | 1.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 141M | -45M | 260M | 12M |
Operating income | 164M | 663M | 94M | 931M |
Non operating interest income | ||||
Income | 228M | -632M | 72M | 388M |
Expense | 501M | -497M | 351M | 698M |
Other income expense | — | — | — | — |
Pretax income | -71M | 34M | 53M | 470M |
Tax provision | -11M | 74M | 67M | -9M |
Net income | -81M | -42M | 181M | -161M |
Basic EPS | 0.0 | — | — | — |
Diluted EPS | 0.0 | — | — | — |
Basic average shares | 21.3B | — | — | — |
Diluted average shares | 21.3B | — | — | — |
EBITDA | 1.2B | 525M | 1.1B | 1.7B |
Net income from continuing op. | -60M | -40M | -14M | 479M |
Minority interests | -43M | -59M | -44M | -85M |
Preferred stock dividends | 0 | 0 | 0 | 0 |